Lonza’s CocoonTM manufacturing platform will be used by Israel’s largest hospital, Sheba Medical Center at Tel Hashomer, to develop point-of-care cell-therapy manufacturing. Cocoon has been designed ...
Add Yahoo as a preferred source to see more of our stories on Google. Swiss pharmaceutical group Lonza's world’s largest dedicated cell and gene therapy facility in Houston ZURICH (Reuters) - Lonza ...
The Sheba Medical Center at Tel Hashomer will collaborate with Switzerland’s Lonza Group to develop gene therapies for leukemia and lymphoma in a faster and cheaper way. The hospital said it will use ...
BASEL, Switzerland & MONTRÉAL & AUSTIN, Texas--(BUSINESS WIRE)--Lonza and Triumvira Immunologics ("Triumvira") announced that the first patient has been dosed with Triumvira's investigational T-cell ...
Under the terms of the collaboration, Leucid will utilise Lonza as its preferred manufacturer, aiming to deliver high quality cell therapies quickly and cost-effectively to patients in a decentralized ...
ZURICH (Reuters) - Lonza said on Tuesday the first patient has been treated with a cell therapy made in its "Cocoon" platform, which the Swiss contract drug maker hopes catches on at medical centers ...
ZURICH, Sept 8 (Reuters) - Lonza (LONN.S), opens new tab said on Tuesday the first patient has been treated with a cell therapy made in its "Cocoon" platform, which the Swiss contract drug maker hopes ...
ZURICH (Reuters) - Lonza said on Tuesday the first patient has been treated with a cell therapy made in its "Cocoon" platform, which the Swiss contract drug maker hopes catches on at medical centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results